On this page
Ixinity
Coagulation Factor IX (Recombinant)
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Ixinity
Proper name
Coagulation Factor IX (Recombinant)
Licence type
351(a)
BLA number
125426
Applicant
Medexus Pharma, Inc.
Center
CBER
Presentations
6
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 1000IU | For Injection | Intravenous | Single-Dose Vial | Rx | April 29, 2015 |
| 1500IU | For Injection | Intravenous | Single-Dose Vial | Rx | April 29, 2015 |
| 2000IU | For Injection | Intravenous | Single-Dose Vial | Disc | December 21, 2015 |
| 250IU | For Injection | Intravenous | Single-Dose Vial | Disc | December 21, 2015 |
| 3000IU | For Injection | Intravenous | Single-Dose Vial | Rx | December 21, 2015 |
| 500IU | For Injection | Intravenous | Single-Dose Vial | Disc | April 29, 2015 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |